Sökresultat

Filtyp

Din sökning på "*" gav 125556 sökträffar

Prince Daniel’s Research Grant to Andreas Edsfeldt!

This year Prince Daniel's grant for particularly promising young researchers was awarded WCMM researcher Andreas Edsfeldt for his research on atherosclerosis in type 2 diabetes. The Swedish Heart-Lung Foundation wishes to foster the next generation of young researchers. One way in which it does this is by awarding grants to particularly promising young researchers. Andreas Edsfeldt, associate prof

https://www.wcmm.lu.se/article/prince-daniels-research-grant-andreas-edsfeldt - 2026-05-29

Get to know the Scientific Advisory Board

For those of you that maybe did not know, WCMM Lund has a Scientific Advisory Board (SAB) composed of four internationally recognized experts. Two of them know the WCMM Centre quite well by now and the other two are just newly recruited. The role of the WCMM SAB is to provide strategic guidance and direction the WCMM Centre regarding scientific aspects, strategic directions and provides recommenda

https://www.wcmm.lu.se/article/get-know-scientific-advisory-board - 2026-05-29

Welcome Chimezie Harrison Umeano!

Chimezie Harrison Umeano is a new graduate student in regenerative immunology at Nicholas Leigh’s lab. He has a background in biochemistry and biomedicine and has previously been engaged as a laboratory technician at the Karolinska Institute. Chimezie is interested in how highly regenerative species like salamanders modulate their immune system to promote regeneration. As a graduate student, his p

https://www.wcmm.lu.se/article/welcome-chimezie-harrison-umeano - 2026-05-29

Swedish Medical Products Agency grants approval for clinical study of new stem cell based Parkinson’s Disease treatment

An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval of the trial has already been obtained from the Swedish Ethics Review Authority, and the STEM-PD team, led from Lund University in Sweden, is thereby ready to proceed with the trial. WCMM members Agnete Kirkeby and Gesin

https://www.wcmm.lu.se/article/swedish-medical-products-agency-grants-approval-clinical-study-new-stem-cell-based-parkinsons - 2026-05-29

Open position!

The Pereira group is seeking for 1 post-doctoral candidate for a collaborative project with the company Asgard therapeutics. The Pereira group has pioneered cell fate reprogramming approaches in immunology with induced dendritic cells (Rosa et al, Science Immunology 2018; Rosa et al, Science Immunology 2022) and has shown recently that the same combination of factors can reprogram tumor cells into

https://www.wcmm.lu.se/article/open-position - 2026-05-29

New publication in Science Translational Medicine

The Bourgine lab has published a new article in Science Translational Medicine reporting the fast and standardized generation of human mini-bones/humanized ossicles, and assess to what extent they can reflect the human bone marrow microenvironment. Human ossicles consist of fully mature bone and bone marrow structures establishing a complex human mesenchymal niche with retained stem cell propertie

https://www.wcmm.lu.se/article/new-publication-science-translational-medicine - 2026-05-29

New webpage

This article is over 5 years old, and the information may therefore be outdated. New webpage has been created and a change of technology Due to updates in technology a brand new webpage for WCMM has now been created. We hope you find this to your liking.

https://www.wcmm.lu.se/article/new-webpage - 2026-05-29

The role of cell death in diabetes-associated cardiovascular disease

WCMM researcher Andreas Edsfeldt has been awarded the SSMF consolatory grant, a five-year grant that gives prominent researchers the opportunity to strengthen their position as independent researchers, for his research on the role of cell death in diabetes-associated cardiovascular disease. Diabetes mellitus type 2 (T2D) is rapidly increasing worldwide, and people with T2D have a clearly increased

https://www.wcmm.lu.se/article/role-cell-death-diabetes-associated-cardiovascular-disease - 2026-05-29

19.5 MSEK to clinical WCMM researcher!

Sandra Lindstedt has received 19.5 MSEK, the grant for clinical studies within therapy research from the Swedish Research Counsil, for her project entitled “Cytokine filtration at lung transplantation”. This grant aims to enable a constellation of researchers within regions and academia to work towards a common research goal. The purpose is to provide support for clinical therapy studies that are

https://www.wcmm.lu.se/article/195-msek-clinical-wcmm-researcher - 2026-05-29

New treatment for aggressive breast cancer

This article is over 5 years old, and the information may therefore be outdated. Approximately 10–15 per cent of breast cancer cases do not respond to treatment with hormone therapy, which means that they are more aggressive and often recur. An international research team led by researchers at Lund University in Sweden has uncovered a way to treat these aggressive tumours through manipulation of t

https://www.tcr.lu.se/article/new-treatment-aggressive-breast-cancer - 2026-05-29

PI Emma Hammarlund receives ERC grant

This article is over 5 years old, and the information may therefore be outdated. Six LU researchers receive ERC Starting Grants Colourful common wall lizards, an innovative X-ray microscope and advanced research on Alzheimer’s, leukaemia, photographic evidence and the origin of life. Six researchers from Lund University in Sweden have been granted five-year starting grants totalling EUR 9.5 millio

https://www.tcr.lu.se/article/pi-emma-hammarlund-receives-erc-grant - 2026-05-29

Promising treatment for aggressive childhood cancer

This article is over 5 years old, and the information may therefore be outdated. A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine. Every year, about 800 children in the US are diagnosed with neuroblastoma, an aggressi

https://www.tcr.lu.se/article/promising-treatment-aggressive-childhood-cancer - 2026-05-29

Oxygen-sensing mechanisms across eukaryotic kingdoms and their roles in complex multicellularity

This article is over 5 years old, and the information may therefore be outdated. Emma Hammarlund and Sofie Mohlin at TCR, together with two colleagues from Oxford University, have reviewed how oxygen-sensing mechanisms across eukaryotic kingdoms are alike. From a functional perspective, these systems are active at low oxygen and degraded at high, although their scope varies.    2020-11-16_hammarlu

https://www.tcr.lu.se/article/oxygen-sensing-mechanisms-across-eukaryotic-kingdoms-and-their-roles-complex-multicellularity - 2026-05-29

PI:s at TCR receive Cancerfonden grants

This article is over 5 years old, and the information may therefore be outdated.  Big congratulations to PI:s Daniel Bexell Novel treatment for high-risk neuroblastoma, Christer Larsson Mechanisms determining breast cancer cell fate upon death receptor stimulation - apoptosis or a change in phenotype, Ramin Massoumi Targeted therapy against metastatic melanoma and Sofie Mohlin An Embryonic Model i

https://www.tcr.lu.se/article/pis-tcr-receive-cancerfonden-grants - 2026-05-29

Coming up: LUCC Imaging & nuclear medicine/radiology seminar

This article is over 5 years old, and the information may therefore be outdated. SAVE THE DATE for this upcoming event. Dear all, We hope you are all keeping yourselves safe and healthy through this challenging time.We would like to cordially invite you to a digital imaging meeting including short presentations and discussions about existing imaging facilities and the need for development of the i

https://www.tcr.lu.se/article/coming-lucc-imaging-nuclear-medicineradiology-seminar - 2026-05-29

PI:s at TCR receive Cancerfonden grants

Big congratulations to PI:s Håkan Axelson Transformation of renal epithelial cells: the nephron and renal cell carcinoma, Anders Bjartell Integration of Biomarkers in Clinical Models for Improved Outcome Prediction and New Therapies in Prostate Cancer, Emma Hammarlund Utilizing the isotopic elemental fingerprint of cancer to understand tumorgenesis and for the development of truly non-invasive dia

https://www.tcr.lu.se/article/pis-tcr-receive-cancerfonden-grants-0 - 2026-05-29

New Cancerfonden grants

Big congratulations to: Alexander Pietras, The irradiated brain tumor microenvironment: Biology and therapeutic tagets, on receiving Senior Investigator Award, and to Paulina Bolivar, in Kristian Pietras group, Integrative single-cell and spatial analyses to reveal micriniche organization in the tumor microenvironment of triple negative breast cancer, on receiving Postdoc grant from Cancerfonden.

https://www.tcr.lu.se/article/new-cancerfonden-grants - 2026-05-29

Millions in funding for PI Daniel Bexell

This article is over 5 years old, and the information may therefore be outdated. PI Daniel Bexell has been awarded millions in funding from Åke Wibergs foundation that goes to young PIs in medical research. One of the aims is to find out why some tumors develop resistance to today’s treatment but also to find new treatment strategies. Every year around 20 children in Sweden are diagnosed with Neur

https://www.tcr.lu.se/article/millions-funding-pi-daniel-bexell - 2026-05-29

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence

This article is over 5 years old, and the information may therefore be outdated. The platelet-derived growth factor (PDGF) signalling pathway is often dysregulated in cancer and PDGF-receptor expression has been linked to unfavourable prognostic factors in breast cancer (e.g. ER negativity, high Ki67 and high grade). This study aimed to evaluate the expression of PDGFRα, PDGFRβ and ligand PDGF-CC

https://www.tcr.lu.se/article/pdgf-pathway-breast-cancer-linked-tumour-aggressiveness-triple-negative-subtype-and-early-recurrence - 2026-05-29